Znn3bq.jpeg
²é¿´: 2713  |  »Ø¸´: 3

sukeharu

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] siRNA knockdown

×î½üÔÚ¿´»ùÒò¸ß³ýµÄÎÄÕ£¬´òËãÏÂÃæ¿ªÊ¼×öÕâ·½ÃæµÄÄÚÈÝ¡£µ«ÊǶÔÎÄÕÂÖгöÏÖµÄÖÊÁ££¬ÔØÌåʲôµÄ²»ÊÇÌ«Á˽⡣ϣÍûÄܵõ½´ó¼ÒµÄ°ïÖú£¬·Ç³£¸Ðл¡£
ÏÂÃæÊÇһƪÎÄÕ£¬ÀïÃæµÄÖÊÁ£Ê²Ã´µÄÀ´Ô´£¬²éÁËÖ®ºóûÓÐÕÒµ½£¬²»ÖªÊÇÖÊÁ£Ãû³ÆµÄÊéдÓÐÎÊÌ⣬»¹ÊÇÆäËüµÄ£¬´ó¼Ò¿É·ñ°ïÎÒ¿´¿´¶¼ÊÇʲô£¨×îºÃÊÇÓÐMAPͼʲôµÄ£©£¬´ÓÄÄÀï¿ÉÒÔÂòµ½¡£
Sample Text
The mU6 pro vector containing the mouse U6 promoter (36) or the pSilencer 1.0-U6 siRNA expression vector
(Ambion, Austin, TX) was used for the construction of mouse and human Met siRNA expression plasmids. The siRNA target finder and design tool provided
by Ambion was used for selecting the siRNA sequences (see Table 1 footnote). We selected four mouse, three canine, and three human candidate siRNA
sequences from Met mRNA sequences (Table 1) to minimize possible nonspecific reactivity with target sequences. Moreover, these sequences also
survived a BLAST search to exclude coding sequences with 17 or more contiguous base pairs of homology to other genes. The oligonucleotides that
encode the Met mRNA 19-mer hairpin sequences were cloned into an expression vector plasmid (the BbsI and XbaI sites in the mU6 pro vector and the
ApaI and EcoRI sites in the pSilencer 1.0-U6 vector) and tested for Met suppression activity in either mouse or human cells, respectively.
Sample Text
For the construction of recombinant adenoviruses, the AdEasy Adenoviral Vector
System (human adenovirus serotype 5, or Ad5; Stratagene, La Jolla, CA) was used. First, we recloned the selected siRNA sequences with the U6 promoter
into a pShuttle vector. As a mock vector, U6 promoter without the siRNA sequence was used. Then, pShuttle vectors containing siRNA sequences were
linearized with PmeI and cotransformed with pAdEasy-1 into BJ5183 cells by electroporation. Positive (homologously recombined) clones were selected and
confirmed by PacI digestion. Adenoviral DNA plasmids with the correct insert were transformed into TOP10-competent cells (Invitrogen, Carlsbad, CA) and
amplified. The linearized adenoviral DNA was prepared by digesting the plasmid with PacI, after which it was transfected into the packaging cell line
HEK293. Transfected cells were cultured for 7 days, and the virus was harvested. After repeating one more amplification cycle, large-scale amplification
was done by with Cell Factory tissue culture plates (Nunclon, Nalge Nunc International, Rochester, NY). Purification of the virus was done either
by CsCl ultracentrifugation or by PEG8000 precipitation. The titer of the virus was evaluated through endpoint dilution.
Sample Text
Cells at 75 to 80% confluency were infected with Ad Met siRNA diluted in a small volume of growth medium containing 10%
fetal bovine serum at a multiplicity of infection (m.o.i.) of 10 to 100 for 4 hours at 37¡ãC. After 4 hours, fresh complete growth medium was added, and the cells
were cultured in a CO2 incubator at 37¡ãC. After 2 to 4 days in culture, the adenovirus-infected cells were collected for Western blotting, proliferation
assays, invasion assays, or morphologic analyses.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sukeharu

½ð³æ (СÓÐÃûÆø)

±êÌâ±¾À´ÊÇÒª¼Ó´ÖµÄ£¬µ«ÊǺÃÏñÖ±½ÓûÓÐÁË£¬ÎÒÔÙ²¹³äÏ¡£
1. Met siRNA Expression Plasmids.
2. Construction of c-met siRNA Adenoviruses (Ad Met siRNA)
3. Adenovirus Infection
2Â¥2016-04-20 10:34:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sayen

Òø³æ (СÓÐÃûÆø)

ÊÇÒ»¸ö²¡¶¾ÔØÌ壬º¬ÓÐÄ¿µÄ»ùÒòµÄ¸ÉÈÅRNA£¬°ÑÕâ¸ö²¡¶¾ÖÊÁ£×ªÈëϸ°û±í´ï¸ÉÈÅRNA£¬³ÁĬĿµÄ»ùÒò

·¢×ÔСľ³æAndroid¿Í»§¶Ë
3Â¥2016-04-20 11:34:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sukeharu

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
3Â¥: Originally posted by sayen at 2016-04-20 12:34:25
ÊÇÒ»¸ö²¡¶¾ÔØÌ壬º¬ÓÐÄ¿µÄ»ùÒòµÄ¸ÉÈÅRNA£¬°ÑÕâ¸ö²¡¶¾ÖÊÁ£×ªÈëϸ°û±í´ï¸ÉÈÅRNA£¬³ÁĬĿµÄ»ùÒò

Êǵģ¬Ö»ÊÇÕâ¸öÔØÌ壬ÎÒ¸ù¾ÝËûËùдµÄÃû³ÆºÍ¹«Ë¾£¬Ôõô²é²»µ½ÄØ£¿ÊÇÄÄÀï³öÎÊÌâÁËÂð£¿
4Â¥2016-04-20 12:25:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ sukeharu µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é +23 hualkop 2026-04-12 25/1250 2026-04-16 22:12 by SUSE_CL
[¿¼²©] É격×Ô¼ö +3 LinxiaÁÖÏÄ 2026-04-13 3/150 2026-04-16 12:55 by Ä«ºÉ֮¶
[¿¼ÑÐ] 279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ 20+7 ¹Â¶ÀµÄÀǰ®³ÔÑò 2026-04-12 29/1450 2026-04-16 09:00 by screening
[¿¼ÑÐ] ÇóÖúµ÷¼Á£¬¿çµ÷ +19 XÊ®¸¦´çY 2026-04-11 20/1000 2026-04-15 21:18 by cuisz
[¿¼ÑÐ] 085801µçÆø×¨Ë¶272Çóµ÷¼Á +19 µçÆøÀî 2026-04-13 21/1050 2026-04-15 13:37 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 366Çóµ÷¼Á +11 ²»ÖªÃûµÄСئ 2026-04-11 11/550 2026-04-14 15:50 by zs92450
[¿¼ÑÐ] ¿¼Ñе÷¼Á +13 ³¤¹­°Á 2026-04-13 14/700 2026-04-14 14:44 by zs92450
[¿¼ÑÐ] ¿¼ÑÐÓ¢Ò»ÊýÒ»338·Ö +9 ³¤½­´óѧ¶«Ð£Çø 2026-04-13 10/500 2026-04-14 00:41 by Íõ¬Bè±
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã´óÉúÎï325·ÖÇóµ÷¼Á +9 zysheng 2026-04-12 9/450 2026-04-12 22:31 by yuyin1233
[¿¼ÑÐ] 346·Ö£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +6 moser233 2026-04-12 7/350 2026-04-12 22:11 by fqwang
[¿¼ÑÐ] 296Çóµ÷¼Á +14 Íô£¡£¿£¡ 2026-04-10 16/800 2026-04-12 10:48 by zhouyuwinner
[¿¼ÑÐ] 307Çóµ÷¼Á +10 tzq94092 2026-04-10 10/500 2026-04-12 08:18 by wise999
[¿¼ÑÐ] 0854µ÷¼Á +5 ÒôÏñµêÌý»¨¹ÄÏ· 2026-04-10 5/250 2026-04-11 10:49 by qingpingzhu
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +6 Say Never 2026-04-10 6/300 2026-04-11 10:33 by wwj2530616
[¿¼ÑÐ] 281Çóµ÷¼Á +11 ¾õµÃºÃµÄ°É 2026-04-10 11/550 2026-04-11 09:35 by ÄæË®³Ë·ç
[¿¼ÑÐ] 342µç×ÓÐÅϢר˶Çóµ÷¼Á +9 ÄãÈÃÎÒÔõôÀóÖ¦ 2026-04-10 10/500 2026-04-11 08:33 by zhq0425
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤µ÷¼Á +12 ·ñ¼«Ì©À´2026 2026-04-10 13/650 2026-04-11 00:28 by wangjihu
[¿¼ÑÐ] 0858Çóµ÷¼Á 5+5 Gky09300550£¬ 2026-04-10 8/400 2026-04-10 19:13 by chemisry
[¿¼ÑÐ] ±¾9 Ò»Ö¾Ô¸Î÷¹¤´ó085601 324Çóµ÷¼Á +5 wysyjs25 2026-04-10 5/250 2026-04-10 16:57 by luoyongfeng
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û